multivalent tick antigenic peptide-based vaccine(L2 Diagnostics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namemultivalent tick antigenic peptide-based vaccine(L2 Diagnostics)
Drug Alias NameN/A
ClassificationVaccinesBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsLyme Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesL2 Diagnostics LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesL2 Diagnostics LLC
Active IndicationsN/A
Inactive IndicationsLyme Disease

Other Information

ATC CodeN/A
Related LinksN/A